BackRegeneron Pharmaceuticals Overview
Regeneron Pharmaceuticals, Inc.

Regeneron Pharmaceuticals Target Price

Analysts' 12-month price predictions for REGN.

Share Price

$483.07

Average Target Price

$816.0068.9% upside

3 analysts in the last 4 months

High: $903 | Low: $695

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2025-04-22Cantor FitzgeraldCarter Gould$69543.9% upsideOpen
2025-04-22Canaccord GenuityJohn Newman$85076% upsideOpen
2025-03-14BMO Capital$90386.9% upsideOpen
2024-11-01Leerink PartnersAndrew Berens$88082.2% upsideOpen
2024-11-01BMO CapitalEvan David Seigerman$1,190146.3% upsideOpen
2024-11-01Piper SandlerChristopher Raymond$1,195147.4% upsideOpen
2024-10-31Evercore ISICory Kasimov$1,170142.2% upsideOpen
2024-10-24Evercore ISICory Kasimov$1,175143.2% upsideOpen
2024-10-23Wells FargoMohit Bansal$1,050117.4% upsideOpen
2024-09-24Goldman SachsSalveen Richter$1,292167.5% upsideOpen
2024-09-24Truist FinancialThomas Klee$1,200148.4% upsideOpen
2024-09-24Leerink PartnersDavid Risinger$1,077122.9% upsideOpen
2024-09-24Robert W. BairdBrian Skorney$94094.6% upsideOpen
2024-09-12BMO CapitalEvan David Seigerman$1,300169.1% upsideOpen
2024-09-09RBC CapitalBrian Abrahams$1,282165.4% upsideOpen
2024-08-23Raymond JamesChristopher Raymond$1,242157.1% upsideOpen
2024-08-02RBC CapitalBrian Abrahams$1,240156.7% upsideOpen
2024-08-02Bank of America SecuritiesGeoff Meacham$80566.6% upsideOpen
2024-07-19Raymond JamesChristopher Raymond$1,166141.4% upsideOpen
2024-07-18GuggenheimYatin Suneja$1,180144.3% upsideOpen
2024-07-12UBSTrung Huynh$1,250158.8% upsideOpen
2024-07-11Morgan StanleyTerence Flynn$1,182144.7% upsideOpen
2024-06-25Argus ResearchJasper Hellweg$1,170142.2% upsideOpen
2024-06-13RBC CapitalBrian Abrahams$1,299168.9% upsideOpen
2024-06-12RBC CapitalBrian Abrahams$1,229154.4% upsideOpen
2024-06-04RBC CapitalBrian Abrahams$1,200148.4% upsideOpen
2024-06-03BMO CapitalEvan David Seigerman$1,082124% upsideOpen
2024-05-20Raymond JamesChristopher Raymond$1,000107% upsideOpen
2024-05-13Evercore ISICory Kasimov$1,150138.1% upsideOpen
2024-05-03RBC CapitalBrian Abrahams$1,185145.3% upsideOpen
2024-04-12JefferiesAkash Tewari$1,060119.4% upsideOpen
2024-04-11RBC CapitalBrian Abrahams$1,189146.1% upsideOpen
2024-03-13Morgan StanleyMatthew Harrison$1,115130.8% upsideOpen
2024-01-12BMO CapitalBrian Abrahams$1,076122.7% upsideOpen
2024-01-12RBC CapitalBrian Abrahams$1,076122.7% upsideOpen
2023-03-27Leerink PartnersAndrew Berens$976102% upsideOpen
2023-03-24JefferiesAkash Tewari$92591.5% upsideOpen
2023-02-08EF Hutton$85376.6% upsideOpen
2023-02-06Leerink Partners$83472.6% upsideOpen
2023-02-06RBC Capital$78762.9% upsideOpen
2023-02-06Morgan Stanley$88382.8% upsideOpen
2022-11-11Guggenheim$91589.4% upsideOpen
2022-10-03Goldman Sachs$970100.8% upsideOpen
2022-09-16Canaccord Genuity$75055.3% upsideOpen
2022-09-13Piper Sandler$77560.4% upsideOpen
2022-09-12Wells Fargo$80065.6% upsideOpen
2022-09-09Barclays$81568.7% upsideOpen
2022-09-09Morgan StanleyMatthew Harrison$85176.2% upsideOpen
2022-09-08JefferiesAkash Tewari$67539.7% upsideOpen
2022-08-15Morgan StanleyMatthew Harrison$62529.4% upsideOpen